The Medicare Drug War:
Drug Companies and HMOs Led an Army of
Nearly 1,000 Lobbyists to Promote Misguided
Legislation and Increase Profits

• Executive Summary •
• Full Report in PDF Format •   • Press Release •


Appendices A & B •  • Appendices C & D •

To help push through Medicare prescription drug legislation that will safeguard their bottom lines at the expense of America’s taxpayers, the pharmaceutical industry, HMOs and related interests spent nearly $141 million on Washington lobbying in 2003. Drug companies, HMOs, their trade associations and industry-funded advocacy groups deployed at least 952 lobbyists to do their bidding on Capitol Hill and at the White House. --June 22, 2004